News

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
Everyone’s alopecia areata is different. Even though everyone who has it experiences hair loss, it may have many variations, including where, when, and how often you lose your hair. Alopecia ...
Alopecia areata risk also has possible positive correlations with levels of N-acetylarginine (OR, 1.31; 95% CI, 1.03-1.65; P = .025) and 12 additional serum metabolites.
Alopecia areata can make both your professional and personal life hard to navigate. Research has found that as many as 1 in 6 people are uncomfortable having contact with someone who has hair ...
Alopecia areata affects millions of Americans regardless of age, race, or gender, manifesting as patchy hair loss across the scalp and sometimes other body areas. This autoimmune condition occurs ...
The most-read alopecia articles published on AJMC.com in 2024 include topics on Janus kinase inhibitors, new therapeutic strategies, health-related quality of life measurements, potential links to ...
For prolonged alopecia areata, researchers found significantly higher odds for this outcome with comorbid Hashimoto’s thyroiditis (OR = 1.911; 95% CI, 1.328-2.748), ...
What is alopecia areata, anyway? Alopecia areata is an autoimmune condition that causes sudden and patchy hair loss—mostly on the scalp, but can also affect the face and other parts of the body ...
Shamsha Damani has lived with alopecia areata since she was six, which turned into alopecia universalis in 2013. She's a fierce advocate for those with alopecia areata and currently serves on the ...